Tag: COVAXIN

As the nation launches the world’s largest preventive-health vaccine, Apollo Hospitals begins vaccinating healthcare workers

As the nation launches the world’s largest preventive-health vaccine, Apollo Hospitals begins vaccinating healthcare workers

Hyderabad: After a long year spent fighting the COVID pandemic, hope and positivity was palpable in the air as the COVID vaccination program began at the Apollo Vaccination Centre in Chennai today. The Apollo Vaccination Centre is one of the 3000 sites across the country selected to vaccinate over 3 lakh healthcare workers on the first day of the national COVID vaccination drive. The vaccination program saw the vaccine being administered to healthcare workers at the COVID frontlines beginning with Dr Prathap C. Reddy, Chairman, Apollo Hospitals Group who received the first dose.

Speaking on the occasion, Dr Prathap C. Reddy, Chairman, Apollo Hospitals Group said, “The vaccine marks the turning of the tide in the fight against the novel corona virus that brought the world to its knees for almost a year. The launch of the vaccination program is a critical event, as the last few months have seen a second wave of infections sending many countries in Europe into a fresh series of lockdowns, and a vaccine is the need of the hour to prevent and reduce new infections. I commend the Government for taking bold steps and fast tracking the vaccine approval to ensure that India’s citizens are safe and armed with a vaccine to fight the virus.”

He added, “For India, this is a landmark moment as the vaccines are being manufactured in the country itself, with one a product of indigenous R&D. This is a proud moment and a milestone in our efforts to become self-reliant or atma nirbhar in the field of healthcare. I am privileged to be the first person in Apollo Hospitals to receive the vaccine dose here today. I am sure that this will strengthen the resolve of our frontline workers to continue to serve patients and win the battle against COVID-19.”

The immunization programme at the Apollo Vaccination Centre abided by the recommended Government protocols. The healthcare workers scheduled to receive their first vaccine dose followed proper physical distance. There was proper checking of identities before administration of the vaccine shots with cold chain maintenance, proper biomedical waste management, validation of data in Co-WIN app, observation for 30minutes post vaccination, AEFI (adverse effects following immunization) management and above all a comforting and reassuring environment to reassure those present for the vaccine shots. During vaccination, the entire process of infection control practices were followed including screening of all beneficiaries for fever, physical distance, hand hygiene, universal masking, and safe injection practices.

The launch of the vaccination programme was the culmination of months of preparation that included preparing the infrastructure, planning the distribution, training programs, dry runs, and ensuring that both the public and private healthcare work together in this mammoth task.The Tamil Nadu government had received 5,56,500 doses of the COVID-19 vaccines including 5,36,500 doses of Covishield and 20,000 doses of Covaxin for today’s vaccination drive held at 307 locations across the state.

At Apollo Hospitals, the work began in October itself to strengthen the vaccine cold chain and gear up the facilities for efficient and fast administration by trained healthcare personnel with the highest safety standards, for up to 1 million doses per day. Over the next weeks, the COVID-19 vaccine rollout in the country will cover 30 million frontline healthcare workers across over 3,000 sites, and Apollo Hospitals is ready to play an integral role in the vaccination process. The vaccination of the healthcare workers is to be followed by vaccination of other frontline workers such as police, local administration and revenue officials, and later persons above the age of 50, and then, those aged below 50 but with co-morbidities.

SRM Hospital launches third phase of COVAXIN trail; Seeks volunteers

Kattankulathur: “SRM Medical College Hospital and Research Centre (SRM MCHRC), Kattankulathur has successfully completed two phases of human testing of the COVAXIN trial and the third phase for the same will start today (7th December 2020), said SRM MCHRC’s Pro-Chancellor (Academics) Dr. P. Sathyanarayanan.
Speaking at a press meet held at the launch of the third phase of the COVAXIN trail in the hospital, he said that the number of patients who will be tested in this final phase will be over 1000.

“Until now we have received 500 volunteers for the test. We will be taking in more volunteers till the end of December 2020. We are trying our best to make this work, as it will be India’s first indigenous vaccine,” he added.
Also present with SRM MCHRC’s Pro-Chancellor (Academics) Dr. P. Sathyanarayanan were Pro Vice-Chancellor (Medical and Health Sciences) Dr. Lt Col Dr. A. Ravi Kumar, Dean Dr. A. Sundaram, Medical Superintendent Dr. K. Thangaraj, Deputy Medical Superintendent Dr. R. Balamurugan, Director (Communication) Mr. R. Nandakummar and Principal Investigator for COVAXIN Dr. Satyajit Mahopatra along with Dr. Melvin George.

“Any person above 18 years of age and had not suffered COVID19 illness in the past can participate as a volunteer in this trial. Pregnant women are excluded. The vaccine shot will be administered twice – 28 days apart,” said Principal Investigator for COVAXIN, Dr. Satyajit Mahopatra.

The hospital will be able to conduct the trial for 50 people a day. Once the process is successful, the vaccine will be approved on a fast track basis. SRM MCHRC is currently treating 21 COVID 19 patients and on average 80 people are screened for COVID19.

The first phase of human trials at SRM MCHRC began in July 2020 with 30 volunteers. The second phase was done in August in which 45 volunteers participated. In both these phases, the safety of the vaccine was ascertained. In the trial conducted at SRM hospital, none of the volunteers suffered any serious reactions except for mild fever and body ache.

“SRM MCHRC is the only private Medical College Hospital in Tamil Nadu to undertake this trial. The third phase is to assess the efficacy of the Vaccine in inducing immunogenicity in the human volunteer,” said Dr.Lt Col Dr. A. Ravi Kumar, Pro Vice Chancellor (Medical and Health Sciences).

Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech, Hyderabad in the development of COVAXIN. SRM Medical College Hospital and Research Centre is the only private Medical College Hospital in Tamil Nadu to be selected to carry out all three phases of the COVAXIN trial. This vaccine has got the nod for human trials from the Drug Controller General of India.

“SRM MCHRC is well-equipped with various facilities to handle clinical trials such as COVID 19. It provides 24-hours emergency services and has well-qualified doctors and nurses,” said Dr. A. Sundaram, Dean, SRM MCHRC
The hospital has so far treated 1400 COVID patients since April 2020. Both Allopathy and Siddha medicines in combination are used to treat COVID patients. SRM Medical College Hospital and Research Centre has been doing this under the able guidance of Chancellor Dr. T.R. Paarivendhar and Pro-Chancellor (Academics) Dr. P. Sathyanarayanan.

Those wishing to volunteer for this clinical trial can call 7598951868, 7358026002, 044-47432341 or email to srm.covaxin2020@gmail.com.